Novel |
APMAP |
adipocyte plasma membrane associated protein |
|
|
|
Novel |
POLR3F |
RNA polymerase III subunit F |
- Cytosolic sensors of pathogen-associated DNA
- RNA Polymerase III Chain Elongation
- RNA Polymerase III Transcription Termination
- RNA Polymerase III Abortive And Retractive Initiation
- RNA Polymerase III Transcription Initiation From Type 1 Promoter
- RNA Polymerase III Transcription Initiation From Type 1 Promoter
- RNA Polymerase III Transcription Initiation From Type 2 Promoter
- RNA Polymerase III Transcription Initiation From Type 2 Promoter
- RNA Polymerase III Transcription Initiation From Type 3 Promoter
- RNA Polymerase III Transcription Initiation From Type 3 Promoter
|
|
|
Novel |
SEC23B |
SEC23 homolog B, COPII coat complex component |
|
|
- Congenital dyserythropoietic anemias (CDAs)
|
|
AKAP17A |
A-kinase anchoring protein 17A |
|
|
|
|
APEX2 |
apurinic/apyrimidinic endodeoxyribonuclease 2 |
|
|
|
|
AURKB |
aurora kinase B |
- Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
- APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
- Separation of Sister Chromatids
- Resolution of Sister Chromatid Cohesion
- SUMOylation of DNA replication proteins
- RHO GTPases Activate Formins
- Regulation of TP53 Activity through Phosphorylation
- Mitotic Prometaphase
- Regulation of MECP2 expression and activity
- EML4 and NUDC in mitotic spindle formation
|
- Hesperidin
- AT9283
- Enzastaurin
- Reversine
- Fostamatinib
|
|
|
CBY2 |
chibby family member 2 |
|
|
|
|
CCDC130 |
coiled-coil domain containing 130 |
|
|
|
|
CCDC146 |
coiled-coil domain containing 146 |
|
|
|
|
CCDC33 |
coiled-coil domain containing 33 |
|
|
|
|
CCHCR1 |
coiled-coil alpha-helical rod protein 1 |
|
|
|
|
CLEC1B |
C-type lectin domain family 1 member B |
- GPVI-mediated activation cascade
|
|
|
|
DCTN5 |
dynactin subunit 5 |
- MHC class II antigen presentation
- HSP90 chaperone cycle for steroid hormone receptors (SHR)
- COPI-mediated anterograde transport
- COPI-independent Golgi-to-ER retrograde traffic
|
|
|
|
ELOA |
elongin A |
- Formation of RNA Pol II elongation complex
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Pausing and recovery of Tat-mediated HIV elongation
- Tat-mediated HIV elongation arrest and recovery
- Tat-mediated elongation of the HIV-1 transcript
- HIV elongation arrest and recovery
- Pausing and recovery of HIV elongation
- RNA Polymerase II Pre-transcription Events
- TP53 Regulates Transcription of DNA Repair Genes
- RNA Polymerase II Transcription Elongation
|
|
|
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
- Signaling by ERBB2
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PLCG1 events in ERBB2 signaling
- PIP3 activates AKT signaling
- GRB7 events in ERBB2 signaling
- Downregulation of ERBB2:ERBB3 signaling
- GRB2 events in ERBB2 signaling
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- Constitutive Signaling by Aberrant PI3K in Cancer
- Sema4D induced cell migration and growth-cone collapse
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Downregulation of ERBB2 signaling
- TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
- Constitutive Signaling by Overexpressed ERBB2
- Drug-mediated inhibition of ERBB2 signaling
- Signaling by ERBB2 KD Mutants
- Resistance of ERBB2 KD mutants to trastuzumab
- Resistance of ERBB2 KD mutants to sapitinib
- Resistance of ERBB2 KD mutants to tesevatinib
- Resistance of ERBB2 KD mutants to neratinib
- Resistance of ERBB2 KD mutants to osimertinib
- Resistance of ERBB2 KD mutants to afatinib
- Resistance of ERBB2 KD mutants to AEE788
- Resistance of ERBB2 KD mutants to lapatinib
- Signaling by ERBB2 ECD mutants
- Signaling by ERBB2 TMD/JMD mutants
- Drug resistance in ERBB2 TMD/JMD mutants
|
- Trastuzumab
- Lapatinib
- IGN311
- Trastuzumab emtansine
- Varlitinib
- AV-412
- Pertuzumab
- Afatinib
- Tucatinib
- Tesevatinib
- Fostamatinib
- Brigatinib
- Margetuximab
- Zanubrutinib
|
- Choriocarcinoma
- Pancreatic cancer
- Gastric cancer
- Bladder cancer
- Endometrial Cancer
- Ovarian cancer
- Cholangiocarcinoma
- Breast cancer
- Cervical cancer
|
|
EWSR1 |
EWS RNA binding protein 1 |
|
|
- Ewing's sarcoma
- Myxoid liposarcoma
- Clear cell sarcoma of soft tissue
- Extraskeletal myxoid chondrosarcoma
|
|
EZH2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
- PRC2 methylates histones and DNA
- Oxidative Stress Induced Senescence
- PKMTs methylate histone lysines
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- Regulation of PTEN gene transcription
- Regulation of PTEN gene transcription
- Transcriptional Regulation by E2F6
- HCMV Early Events
|
|
|
|
FAM107A |
family with sequence similarity 107 member A |
|
|
|
|
FAM161A |
FAM161 centrosomal protein A |
|
|
- Retinitis pigmentosa (RP)
|
|
GCC1 |
GRIP and coiled-coil domain containing 1 |
- Retrograde transport at the Trans-Golgi-Network
|
|
|